Production and Characterization of F(Ab')2 Fragments Obtained by Enzymatic Digestion from Murine Anti-MRSA PBP2a Monoclonal Antibodies

Applied Biochemistry and Biotechnology
Anna Erika Vieira de AraujoJosé P M Senna

Abstract

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are a worldwide health problem. In a previous study, a murine monoclonal antibody (mMAB), capable of binding to PBP2a within MRSA strains, was generated. F(ab')2 antibody fragments are widely described in the literature as immunochemical tools and reagents for diagnostics and therapeutics, particularly because of their low immunogenicity and rapid pharmacokinetics. In this study, F(ab')2 fragments from mMAB were generated by enzymatic digestion, using pepsin. They were purified by affinity chromatography using protein A and concentrated by a MWCO 50 kDa filtration unit. The results indicate that it is possible to obtain F(ab')2 fragments by pepsin digestion. ELISA, western blotting, and fluorescence microscopy data demonstrated that F(ab')2 affinity for PBP2a is not lost even after the enzymatic digestion process. As expected, in the pharmacokinetics tests, F(ab')2 presented a faster elimination (between 12 and 18 h) compared to IgG. These F(ab')2 fragments could be used in future immunodiagnostic applications, including in vitro or in situ radiolabeling and in the treatment of infections caused by this important pathogen.

References

Jun 2, 1989·Journal of Immunological Methods·S J BoguslawskiR A Fredrickson
Jun 13, 1988·Journal of Immunological Methods·R KurkelaP Vihko
Sep 1, 1995·Journal of Clinical Microbiology·L A TeixeiraA Tomasz
May 1, 1994·Applied Biochemistry and Biotechnology·P G Seferian, L S Rodkey
Mar 1, 1997·The Journal of Pharmacy and Pharmacology·M I Bazin-RedureauJ M Scherrmann
Aug 30, 2001·Journal of Clinical Microbiology·W J MasonM S Smeltzer
Feb 16, 2006·Drug Discovery Today·Mohammad A TabriziLorin K Roskos
Jan 30, 2008·Current Protocols in Cell Biology·Sarah M Andrew, Julie A Titus
Dec 2, 2010·Memórias do Instituto Oswaldo Cruz·Pricilla D M de MatosKátia Regina N dos Santos
Dec 24, 2010·Clinical and Vaccine Immunology : CVI·Hidehito MatsuiSatoshi Omura
Jan 12, 2011·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Jeannete ZuritaManuel Guzmán-Blanco
Jan 11, 2011·Médecine et maladies infectieuses·P Tattevin
Mar 4, 2011·Methods in Molecular Biology·Biji T KurienR Hal Scofield
Mar 19, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sukanda KittipongwarakarnWim Jiskoot
Apr 18, 2014·The New England Journal of Medicine·Flávia RossiCesar A Arias
Aug 25, 2015·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·José Procópio M SennaRicardo Galler
Nov 28, 2016·Journal of Global Antimicrobial Resistance·S M PurrelloS Stefani
Feb 18, 2017·Applied Biochemistry and Biotechnology·Ana Paula Corrêa ArgondizzoMarco Alberto Medeiros

❮ Previous
Next ❯

Citations

Mar 14, 2018·Microorganisms·Pietro SpezialeGiampiero Pietrocola

❮ Previous
Next ❯

Related Concepts

Related Feeds